$9.94+2.90%
2026-10-09 close · prelimLoading chart…
Candel Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 13 published signal records.
Candel Therapeutics last closed at $9.94 (+2.90%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -8.1×. Its overall grade ranks 275 of 738 stocks in Healthcare.
About this company
Candel Therapeutics last closed at $9.94 (+2.90%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 275/738
Valuation grade A
Related stocks
- AstraZenecaCompetitor
면역항암·종양 치료제 개발 경쟁
- Merck & Co.Competitor
항암제 시장의 대형 경쟁사
- Bristol Myers SquibbCompetitor
면역항암·종양 치료제 경쟁
About Candel Therapeutics
- What technical signals does Candel Therapeutics (CADL) have?
- Candel Therapeutics current technical signals: no active technical signal.
- Is Candel Therapeutics a cup-and-handle pattern?
- No. Candel Therapeutics has no valid Cup signal right now.
- What published figures are available for Candel Therapeutics?
- Market cap: $545.69M. Trailing 12 months PER: -8.1×. Latest quarter PBR: 5.68×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Candel Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy